Cargando…

Blood-brain barrier impairment in MPS III patients

BACKGROUND: Mucopolysaccharidosis type III (MPS III) is an autosomal recessive disorder caused by deficiency of a specific enzyme leading to heparan sulfate (HS) accumulation within cells and to eventual progressive cerebral and systemic organ abnormalities. Different enzyme deficiencies comprise th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garbuzova-Davis, Svitlana, Mirtyl, Santhia, Sallot, Sebastian A, Hernandez-Ontiveros, Diana G, Haller, Edward, Sanberg, Paul R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835134/ https://www.ncbi.nlm.nih.gov/pubmed/24225396 http://dx.doi.org/10.1186/1471-2377-13-174

Ejemplares similares

Blood-Brain Barrier Impairment in an Animal Model of MPS III B
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2011)

Blood-CNS Barrier Impairment in ALS patients versus an animal model
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2014)

Multiple Intravenous Administrations of Human Umbilical Cord Blood Cells Benefit in a Mouse Model of ALS
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2012)

Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2007)

Blood-Brain Barrier Alterations Provide Evidence of Subacute Diaschisis in an Ischemic Stroke Rat Model
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2013)

Plasma derived from human umbilical cord blood: Potential cell‐additive or cell‐substitute therapeutic for neurodegenerative diseases
por: Ehrhart, Jared, et al.
Publicado: (2018)

Reduction of Circulating Endothelial Cells in Peripheral Blood of ALS Patients
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2010)

Reduction of microhemorrhages in the spinal cord of symptomatic ALS mice after intravenous human bone marrow stem cell transplantation accompanies repair of the blood-spinal cord barrier
por: Eve, David J., et al.
Publicado: (2018)

Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2018)

Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2008)

Beneficial Effects of Transplanted Human Bone Marrow Endothelial Progenitors on Functional and Cellular Components of Blood-Spinal Cord Barrier in ALS Mice
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2021)

Human Bone Marrow Endothelial Progenitor Cell Transplantation into Symptomatic ALS Mice Delays Disease Progression and Increases Motor Neuron Survival by Repairing Blood-Spinal Cord Barrier
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2019)

Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2017)

Advancing Stem Cell Therapy for Repair of Damaged Lung Microvasculature in Amyotrophic Lateral Sclerosis
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2020)

Stem cell-derived extracellular vesicles as potential mechanism for repair of microvascular damage within and outside of the central nervous system in amyotrophic lateral sclerosis: perspective schema
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2020)

Extracellular vesicle-based therapy for amyotrophic lateral sclerosis
por: Sadanandan, Nadia, et al.
Publicado: (2021)

Patching Up the Permeability: The Role of Stem Cells in Lessening Neurovascular Damage in Amyotrophic Lateral Sclerosis
por: Monsour, Molly, et al.
Publicado: (2022)

Apolipoprotein A1 Enhances Endothelial Cell Survival in an In Vitro Model of ALS
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2022)

Humoral factors in ALS patients during disease progression
por: Ehrhart, Jared, et al.
Publicado: (2015)

Toward Personalized Cell Therapies: Autologous Menstrual Blood Cells for Stroke
por: Rodrigues, Maria Carolina O., et al.
Publicado: (2011)

Clearance of heparan sulfate in the brain prevents neurodegeneration and neurocognitive impairment in MPS II mice
por: Morimoto, Hideto, et al.
Publicado: (2021)

Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease
por: Sharma, Chanchal, et al.
Publicado: (2022)

Alcohol-Induced Blood-Brain Barrier Impairment: An In Vitro Study
por: Carrino, Donatello, et al.
Publicado: (2021)

The attenuated end of the phenotypic spectrum in MPS III: from late-onset stable cognitive impairment to a non-neuronopathic phenotype
por: Nijmeijer, Stephanie C. M., et al.
Publicado: (2019)

Differences in MPS I and MPS II Disease Manifestations
por: Hampe, Christiane S., et al.
Publicado: (2021)

Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms
por: Viana, Gustavo M., et al.
Publicado: (2020)

Weaknesses of the MPS
por: Holzer, B
Publicado: (2009)

APOE4 impairs blood-brain barrier via cyclophilin A
Publicado: (2012)

Neuropathology of SUDEP: Role of inflammation, blood-brain barrier impairment, and hypoxia
por: Michalak, Zuzanna, et al.
Publicado: (2017)

Targeting the Blood-Brain Barrier to Prevent Sepsis-Associated Cognitive Impairment
por: Nwafor, Divine C, et al.
Publicado: (2019)

Anesthesia and Surgery Impair Blood–Brain Barrier and Cognitive Function in Mice
por: Yang, Siming, et al.
Publicado: (2017)

COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction
por: Chen, Yanting, et al.
Publicado: (2022)

Reactive astrocytes associated with prion disease impair the blood brain barrier
por: Kushwaha, Rajesh, et al.
Publicado: (2023)

Reactive astrocytes associated with prion disease impair the blood brain barrier
por: Kushwaha, Rajesh, et al.
Publicado: (2023)

Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction
por: Abdul Muneer, P M, et al.
Publicado: (2011)

Disturbance of Intracerebral Fluid Clearance and Blood–Brain Barrier in Vascular Cognitive Impairment
por: Ueno, Masaki, et al.
Publicado: (2019)

A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
por: Kadry, Hossam, et al.
Publicado: (2020)

Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers
por: Caligaris, Giulia, et al.
Publicado: (2021)

The Impairment of Blood-Brain Barrier in Alzheimer’s Disease: Challenges and Opportunities with Stem Cells
por: López-Ornelas, Adolfo, et al.
Publicado: (2022)

APOE4 derived from astrocytes leads to blood–brain barrier impairment
por: Jackson, Rosemary J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iaoh0m0643da8pbvf6o6scj5ru